A carregar...
Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era?
For relapsed chemosensitive diffuse large B-cell lymphoma (DLBCL), consolidation with autologous hematopoietic cell transplantation (auto-HCT) is a standard option. With the approval of anti-CD19 chimeric antigen receptor T cells in 2017, the Center for International Blood and Marrow Transplant Rese...
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955408/ https://ncbi.nlm.nih.gov/pubmed/33120429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020007939 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|